Senesco Aktie - SNT

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com

Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com CEOs to take questions in real-time during...

NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.com

NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.com Free educational sessions:...

Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7th

Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7th Company invites Main Street and Wall Street investors...

NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.com

NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.com Free educational sessions: focus on biotech...

Senesco Provides SNS01-T Update on Phase 1b/2a Multiple Myeloma Trial

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) reported today on the progress of its Phase 1b/2a study...

Senesco’s SNS01-T to be Presented During Poster Session at 2012 Annual Meeting of the American Society of Clinical Oncology

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT), announced today that a poster describing the ongoing...

Senesco’s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT), announced today that the characteristics and activity of...

Senesco Technologies Reports Fiscal 2012 Third Quarter Results

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT) today reported financial results for the third quarter...

Senesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Mod...

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT), announced today that an oral presentation will be...

Combination of Lenalidomide and SNS01-T Effective in Cancer Model

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE AMEX: SNT) announced today that a high level of tumor eradication...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

SNT - Frequently Asked Questions (FAQ)

What is the current Senesco share price?

The current share price of Senesco is US$ 0,00

What is the 1 year trading range for Senesco share price?

Senesco has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
ATNMActinium Pharmaceuticals Inc	US$ 1,855 (17,41%)	14,57M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3,45 (11,47%)	48,31M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 3,83 (11,01%)	103,39M
CASSimplify China A Shares Plus Income ETF	US$ 28,92 (10,01%)	8
SOXSDirexion Daily Semiconductor Bear 3X Shares New	US$ 24,86 (8,65%)	36,93M
IBOImpact Biomedical Inc	US$ 2,22 (-32,73%)	1,9M
DJTUT REX 2X Long DJT Daily Target ETF	US$ 18,95 (-16,67%)	13,87k
RIOXDefiance Daily Target 2x Long Riot ETF	US$ 8,99 (-14,87%)	213,67k
ARMUT REX 2X Long ARM Daily Target ETF	US$ 21,819 (-14,48%)	5,4k
ROBNT Rex 2X Long HOOD Daily Target ETF	US$ 14,58 (-14,34%)	3,46M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 3,83 (11,01%)	103,39M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 18,79 (-8,56%)	95,64M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6,765 (3,44%)	81,84M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 7,28 (-7,14%)	65,14M
DNNDenison Mines Corp	US$ 1,4331 (-2,51%)	62,82M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Senesco Technologies (SNT)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

SNT Neueste Nachrichten

Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com

NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.com

Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7th

NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.com

Senesco Provides SNS01-T Update on Phase 1b/2a Multiple Myeloma Trial

Senesco’s SNS01-T to be Presented During Poster Session at 2012 Annual Meeting of the American Society of Clinical Oncology

Senesco’s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma

Senesco Technologies Reports Fiscal 2012 Third Quarter Results

Senesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Mod...

Combination of Lenalidomide and SNS01-T Effective in Cancer Model

SNT - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Senesco Technologies (SNT) Börsenkurse

Senesco Technologies (SNT)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

SNT Neueste Nachrichten

Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com

NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.com

Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7th

NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.com

Senesco Provides SNS01-T Update on Phase 1b/2a Multiple Myeloma Trial

Senesco’s SNS01-T to be Presented During Poster Session at 2012 Annual Meeting of the American Society of Clinical Oncology

Senesco’s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma

Senesco Technologies Reports Fiscal 2012 Third Quarter Results

Senesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Mod...

Combination of Lenalidomide and SNS01-T Effective in Cancer Model

SNT - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE